Pharmaceutical Technology

JUNE 20, 2023

The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms. Big data is essentially extremely large data sets that can be analysed to reveal patterns, trends, and associations, especially relating to human behaviour and interactions.

Life Science 130

Life Science Clinical Trials Clinical Trials Trials 130

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This has led to the emergence of a new ‘pharmaceutical intelligence’ that has allowed the industry to move away from traditional, slow-moving, and costly processes,” Lyons writes. “AI

Clinical Trials 52

Clinical Trials Clinical Trials Big Data Life Science 52

pharmaphorum

NOVEMBER 24, 2022

Two years ago, the EMA proposed a set of recommendations to unlock the potential of big data for public health, headlined by the creation of a platform to access and analyse healthcare data from across the bloc. With the first data partners on board, the regulator can now move ahead with the start of its first studies.

Big Data 52

Big Data Biobanking Regulation Medicine 52

Roots Analysis

APRIL 4, 2023

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

Big Data 52

Big Data Life Science Development Clinical Trials 52

pharmaphorum

DECEMBER 22, 2021

Within Prime Patient, we have experts in patient strategy, clinical trial recruitment and patient education who are asked for their recommendations on the future of patient engagement by our clients as standard (see summaries). Rise of the machines – big data, AI and machine learning. VP, Clinical Trial Recruitment.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Pharma Companies 105

pharmaphorum

JANUARY 24, 2022

AI in drug discovery is becoming an integral part of the research and development area of treating diseases with more companies incorporating ‘Big Data’ and data scientists within their R&D teams. Engage with regulators about the guidance within machine learning and AI in Drug Discovery.

Drugs 52

Drugs Big Data Scientist Clinical Trials 52

Cloudbyz

SEPTEMBER 3, 2024

With the ability to process and analyze vast amounts of data from various sources, pharmacovigilance professionals can now identify potential safety signals earlier and more accurately, leading to timely interventions and better patient outcomes.

Compliance 52

Compliance Big Data Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 25, 2020

is a clinical stage biopharmaceutical company focused on drug development that utilizes artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BioXcel Therapeutics, Inc.

Trials 40

Trials Production FDA Approval Development 40

XTalks

AUGUST 2, 2023

In September 2022, Roche acquired Good Therapeutics for an upfront payment of $250 million, and has access to their PD-1-regulated IL-2 program. The TPO receptor agonist regulates blood platelet production by binding to and activating TPO receptors on megakaryocyte cells and inducing signalling cascades that increase platelet production.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

pharmaphorum

MARCH 16, 2021

Technologies such as Savana are helping companies augment clinical trials and take a deeper dive into information to extract insights that were previously inaccessible. There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano. AI use in the pandemic.

Doctors 116

Doctors Doctor Life Science Clinical Research 116